Financial results - NORDMED SRL

Financial Summary - Nordmed Srl
Unique identification code: 16185258
Registration number: J13/5543/2004
Nace: 8621
Sales - Ron
364.000
Net Profit - Ron
72.584
Employee
9
The most important financial indicators for the company Nordmed Srl - Unique Identification Number 16185258: sales in 2023 was 364.000 euro, registering a net profit of 72.584 euro and having an average number of 9 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nordmed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 114.672 133.601 150.264 173.702 236.383 240.150 252.763 277.208 332.572 364.000
Total Income - EUR 116.094 133.649 150.367 173.716 236.606 242.389 252.802 283.282 348.032 364.504
Total Expenses - EUR 104.526 120.389 102.930 112.230 151.051 172.561 182.675 211.267 243.674 288.347
Gross Profit/Loss - EUR 11.569 13.259 47.437 61.486 85.555 69.827 70.127 72.015 104.357 76.158
Net Profit/Loss - EUR 9.718 10.927 39.787 53.084 83.106 67.403 67.716 69.442 101.493 72.584
Employees 8 10 8 7 7 8 8 8 8 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 9.8%, from 332.572 euro in the year 2022, to 364.000 euro in 2023. The Net Profit decreased by -28.601 euro, from 101.493 euro in 2022, to 72.584 in the last year.

Check the financial reports for the company - Nordmed Srl

Rating financiar

Financial Rating -
Nordmed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nordmed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nordmed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nordmed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nordmed Srl - CUI 16185258

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 161.283 259.801 246.910 261.959 232.785 273.128 238.733 218.847 281.148 283.846
Current Assets 7.011 11.093 16.845 25.981 12.433 11.046 33.606 12.826 33.746 30.338
Inventories 0 0 0 0 0 0 0 0 0 2.243
Receivables 765 298 1.285 3.711 2.492 2.224 3.317 1.752 16.430 20.614
Cash 6.246 10.795 15.560 22.271 9.941 8.822 30.289 11.074 17.316 7.481
Shareholders Funds 5.633 121.995 150.687 162.107 178.524 160.973 159.512 159.202 191.539 162.358
Social Capital 45 45 89 88 86 84 83 81 81 81
Debts 162.699 148.937 113.068 125.834 66.694 123.202 112.827 72.471 123.354 151.827
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 30.338 euro in 2023 which includes Inventories of 2.243 euro, Receivables of 20.614 euro and cash availability of 7.481 euro.
The company's Equity was valued at 162.358 euro, while total Liabilities amounted to 151.827 euro. Equity decreased by -28.601 euro, from 191.539 euro in 2022, to 162.358 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nordmed Srl

Comments - Nordmed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.